Company Presentations-Thursday Block

10:30 AM - 1:00 PM (EDT), Thursday, June 8, 2023 ・ Session Rooms 103-104C

View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1 in Rooms 103, 104A, 104B, and 104C all four days of Convention.

Company Presentations are accessible to all registered attendees.

Ticker:

Not Provided

Exchange:

Not Provided

Company Type:

Not Provided

Company Website:

Not Provided

Company HQ State:

Not Provided

Company HQ Country:

Not Provided

Year Founded:

Not Provided

Main Therapeutic Focus:

Not Provided

Lead Product in Development:

Not Provided

Development Phase of Primary Product:

Not Provided

Number Of Unlicensed Products (For Which You Are Seeking Partners):

Not Provided

10:30 AM - 10:45 AM

Covant Therapeutics

Covant’s mission is to treat diseases with transformative therapeutics using covalency to modulate…

Session Room 104A

Modulus Discovery, Inc.

Modulus Discovery, Inc., is a pre-clinical stage biotechnology company with a cutting-edge…

Session Room 103

10:45 AM - 11:00 AM

Sarcomatrix Therapeutics Corp.

Sarcomatrix is a pre-clinical biotech developing first-in-class drugs to treat muscle wasting…

Session Room 104A

Ethris

Ethris mission is to redefine mRNA medicines through best-in-industry delivery, stability,and…

Session Room 103

11:00 AM - 11:15 AM

ITabMed

ITabMed Ltd. is a clinical-stage biotech company developing immunotherapy antibodies (ITAbTM) to…

Session Room 103

Novelna Inc.

Novelna Inc. is a biotech start-up, pioneering accurate and affordable screening tests for early…

Session Room 104A

11:15 AM - 11:30 AM

KaliVir Immunotherapeutics, Inc.

KaliVir Immunotherapeutics is a private biotechnology company dedicated to developing systemically…

Session Room 103

Cyrus Biotechnology

Cyrus Biotechnology is a pre-clinical-stage biotech company combining computational protein …

Session Room 104A

11:30 AM - 11:45 AM

PeptiDream Inc.

PeptiDream Inc. (Tokyo Stock Exchange: 4587) is leading the translation of macrocyclic peptides…

Session Room 104A

Phanes Therapeutics, Inc.

Phanes is a clinical stage biotech focused on innovative drug discovery and development in oncology…

Session Room 103

11:45 AM - 12:00 PM

XtalPi

Founded in 2014, XtalPi founders recognized a common hurdle in drug development having to do with…

Session Room 103

NRx Pharmaceuticals, Inc.

Clinical-stage biopharmaceutical company developing therapeutics for the treatment of central…

Session Room 104A

12:00 PM - 12:15 PM

FivepHusion

FivepHusion is an advanced clinical stage biotech company developing Deflexifol™, a novel enhanced…

Session Room 103

12:15 PM - 12:30 PM

Basgenbio Inc.

Basgenbio is a clinico-genomic cohort-based R&D company with K-Biobank, which contains blood…

Session Room 103

12:15 PM - 1:00 PM

Protibea Therapeutics Inc.

Protibea is a clinical stage company whose product has been dosed in 200+ patients for up to one…

Session Room 104A

12:30 PM - 12:45 PM

Henlius Biotech

Henlius is a global biopharmaceutical company with the vision to offer high-quality, affordable,…

Session Room 103

Precision NanoSystems

Precision NanoSystems, now part of the Danaher Life Sciences platform, is a global leader in…

Session Room 104A

12:45 PM - 1:00 PM

Etern Bio

Co-founded by Professor Junying Yuan and Professor Jidong Zhu, two leading scientists in cell death…

Session Room 103

TiCARos

TiCARos is developing very differentiated CAR-T based on our proprietary CAR-T construct designing…

Session Room 104A

3:00 PM - 3:15 PM

Affivant

Affivant is a Basel, Switzerland based biotech company developing innate immune cell engagers for…

Session Room 104B

4:45 PM - 5:00 PM

Accession Therapeutics

Accession Therapeutics is developing a new generation of immunotherapies for solid tumors. …

Session Room 104B